| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.032 |
0.9 |
| mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.0087 |
0.9 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |